Surmodics führt Hochleistungs-ELISA-Substrate für verbesserte Assays ein
Surmodics has launched high-performance ELISA substrates designed to improve assay sensitivity, stability, and reproducibility. The portfolio includes TMB-based formulations with varied reaction rates, along with pNPP and ABTS options, to address challenges such as weak signals and inconsistent results.